LEADER 05542nam 22005775 450 001 9910253931103321 005 20200701150736.0 010 $a3-319-47266-6 024 7 $a10.1007/978-3-319-47266-9 035 $a(CKB)3710000001410438 035 $a(DE-He213)978-3-319-47266-9 035 $a(MiAaPQ)EBC4882070 035 $a(Au-PeEL)EBL4882070 035 $a(CaPaEBR)ebr11399843 035 $a(OCoLC)991571145 035 $a(PPN)202993094 035 $a(EXLCZ)993710000001410438 100 $a20170620d2017 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAntimicrobial Drug Resistance$b[electronic resource] $eClinical and Epidemiological Aspects, Volume 2 /$fedited by Douglas L. Mayers, Jack D. Sobel, Marc Ouellette, Keith S. Kaye, Dror Marchaim 205 $a2nd ed. 2017. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017. 215 $a1 online resource (XXI, 855 p. 61 illus., 32 illus. in color.) 311 $a3-319-47264-X 327 $aHistory of Drug-Resistant Microbes -- Evolutionary Biology of Drug Resistance -- Pharmacology of Drug Resistance -- Drug Development for Drug-Resistant Pathogens -- Genetic Mechanisms of Transfer of Drug Resistance -- Mutations as a Basis of Antimicrobial Resistance -- Altered Drug Targets -- Enzymatic Modification of Drugs -- Reduced Drug Penetration -- Active Efflux Mechanism -- Biofilms -- Beta-Lactamases -- Penicillin Binding Proteins -- Aminoglycosides -- Tetracyclines and ChloramphenicolQuinolones -- Plasmid Mediated Quinolone Resistance to Macrolides, Lincosamides, and Streptogramins -- Mechanisms of Resistance in Metronidazole -- Glycopeptide-resistance in eneterococci -- Daptomycin Resistance -- Oxazolidinones -- PolymyxinsSulfonamides and Trimethoprim -- Antimycobacterial Agents -- Amphotericin (Polyenes) -- Azoles -- Flucytosine -- Echinocandins -- Antifungal Targets, Mechanisms of Action, and Resistance in Candida albicans -- Herpes Nucleoside Drugs -- Influenza Drugs -- HIV Nucleoside Drugs -- HIV Non-Nucleoside Drugs -- HIV Protease Inhibitors -- HIV Entry Inhibitors -- HIV Integrase Inhibitors -- Hepatitis B -- Hepatitis C -- Agents for anaerobic protozoa -- Antimalarial Agents -- Agents for Leishmania -- Agents for Trypanosomes -- Agents for Toxoplasma -- Agents for Cryptosporidium -- Agents against Nematodes -- Agents against Trematodes and Cestodes -- Agents against Ectoparasites. 330 $aThe two volumes included in Antimicrobial Drug Resistance, Second Edition is an updated, comprehensive and multidisciplinary reference covering the area of antimicrobial drug resistance in bacteria, fungi, viruses, and parasites from basic science, clinical, and epidemiological perspectives. This newly revised compendium reviews the most current research and development on drug resistance while still providing the information in the accessible format of the first edition. The first volume, Antimicrobial Drug Resistance: Mechanisms of Drug Resistance, is dedicated to the biological basis of drug resistance and effective avenues for drug development. With the emergence of more drug-resistant organisms, the approach to dealing with the drug resistance problem must include the research of different aspects of the mechanisms of bacterial resistance and the dissemination of resistance genes as well as research utilizing new genomic information. These approaches will permit the design of novel strategies to develop new antibiotics and preserve the effectiveness of those currently available. The second volume, Antimicrobial Drug Resistance: Clinical and Epidemiological Aspects, is devoted to the clinical aspects of drug resistance. Although there is evidence that restricted use of a specific antibiotic can be followed by a decrease in drug resistance to that agent, drug resistance control is not easily achieved. Thus, the infectious diseases physician requires input from the clinical microbiologist, antimicrobial stewardship personnel, and infection control specialist to make informed choices for the effective management of various strains of drug-resistant pathogens in individual patients. This 2-volume set is an important reference for students in microbiology, infectious diseases physicians, medical students, basic scientists, drug development researchers, microbiologists, epidemiologists, and public health practitioners. 606 $aDrug resistance 606 $aInfectious diseases 606 $aDrug Resistance$3https://scigraph.springernature.com/ontologies/product-market-codes/B16020 606 $aInfectious Diseases$3https://scigraph.springernature.com/ontologies/product-market-codes/H33096 615 0$aDrug resistance. 615 0$aInfectious diseases. 615 14$aDrug Resistance. 615 24$aInfectious Diseases. 676 $a616.9041 702 $aMayers$b Douglas L$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aSobel$b Jack D$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aOuellette$b Marc$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aKaye$b Keith S$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aMarchaim$b Dror$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910253931103321 996 $aAntimicrobial Drug Resistance$91910240 997 $aUNINA